Novo Nordisk buys Akero Therapeutics in the US
RefinitivBacaan kurang dari 1 minit
Danish drugmaker Novo Nordisk 
NOVO_B said on Thursday it had agreed to buy United States based Akero Therapeutics, a clinical-stage company developing innovative treatments for patients with serious metabolic diseases marked by a high unmet medical need.
Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini